Patents by Inventor Stefan Stahl

Stefan Stahl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8403306
    Abstract: A device for foaming liquid foods in a container, particularly milk, is provided having a vapor generator for generating vapors, particularly steam, and a vapor lance to be at least partially inserted into the container, with the vapor lance being connected to the vapor generator in a fluid-guiding fashion and including at least one vapor outlet opening such that steam can be discharged from the vapor generator via the vapor lance out of the vapor outlet opening. The device further includes at least one motion element which is connected to the vapor lance and/or a holder for the container such that the vapor lance and the container are movable relative to each other via the motion element.
    Type: Grant
    Filed: March 17, 2010
    Date of Patent: March 26, 2013
    Assignee: Niro-Plan AG
    Inventors: Stefan Stahl, Corinne Keiser, Jochen Ganz, Adrian Burri
  • Publication number: 20130005653
    Abstract: This invention relates to polypeptides which bind to EGFR family receptors and to applications of those polypeptides in medicine, veterinary medicine, diagnosis diagnostics and imaging.
    Type: Application
    Filed: July 16, 2012
    Publication date: January 3, 2013
    Applicant: AFFIBODY AB
    Inventors: FREDRIK NILSSON, TOVE ERIKSSON, ANDREAS JONSSON, STEFAN STÅHL, MIKAELA FRIEDMAN
  • Publication number: 20120304983
    Abstract: A container for holding and dispensing a liquid and/or dissolved active substance, for example a pharmaceutical or cosmetic active substance, has at least one dispensing organ (5) for dispensing, preferably in a portioned manner, the one active substance. Provision is also made for at least two holding chambers (9, 11) separated from one another, at least one of which contains the one active substance and at least one of which contains an at least largely active-substance-free liquid and/or a further active substance differing from the one active substance, wherein the dispensing organ is connected to the at least one chamber containing the active substance for dispensing purposes.
    Type: Application
    Filed: December 24, 2010
    Publication date: December 6, 2012
    Inventors: Jochen Ganz, Josefine Lacour, Alexander Panos, Stefan Stahl
  • Publication number: 20120270801
    Abstract: The disclosure provides a HER3 binding polypeptide, comprising a HER3 binding motif, BM, which motif consists of the amino acid sequence selected from i) EX2X3X4A X6X7EIW X11LPNL X16X17X18QX20 X21AFIX25 X26LX28D, and ii) an N amino acid sequence which has at least 90% identity to the sequence defined in i), wherein the polypeptide binds to the extra-cellular domain of HER3. Also provided is a bispecific ligand having binding affinity for HER3 and for HER2, or for HER3 and for EGFR, and comprising a HER3. binding polypeptide as defined herein and a HER2 binding polypeptide or a EGFR binding polypeptide.
    Type: Application
    Filed: October 27, 2010
    Publication date: October 25, 2012
    Applicant: AFFIBODY AB
    Inventors: Fredrik Frejd, Elin Gunneriusson, Nina Kronqvist, John Löfblom, Stefan Ståhl
  • Patent number: 8247375
    Abstract: This invention relates to polypeptides which bind to EGFR family receptors and to applications of those polypeptides in medicine, veterinary medicine, diagnosis diagnostics and imaging.
    Type: Grant
    Filed: December 5, 2006
    Date of Patent: August 21, 2012
    Assignee: Affibody AB
    Inventors: Fredrik Nilsson, Tove Eriksson, Andreas Jonsson, Stefan Ståhl, Mikaela Friedman
  • Patent number: 7993650
    Abstract: A polypeptide is provided, which has a binding affinity for HER2 and which is related to a domain of staphylococcal protein A (SPA) in that the sequence of the polypeptide corresponds to the sequence of the SPA domain having from 1 to about 20 substitution mutations. Nucleic acid encoding the polypeptide, as well as expression vector and host cell for expressing the nucleic acid, are also provided. Also provided is the use of such a polypeptide as a medicament, and as a targeting agent for directing substances conjugated thereto to cells overexpressing HER2. Methods, and kits for performing the methods, are also provided, which methods and kits rely on the binding of the polypeptide to HER2.
    Type: Grant
    Filed: June 30, 2004
    Date of Patent: August 9, 2011
    Assignee: Affibody AB
    Inventors: Jörgen Carlsson, Stefan Ståhl, Tove Eriksson, Elin Gunneriusson, Fredrik Nilsson
  • Publication number: 20110014339
    Abstract: A device (1, 10) and method for the production of cooled coffee are provided. The device has a brewing unit (4) for the production of coffee, a cooling assembly (11) and a coffee cooler (14) formed as a heat exchanger. The coffee cooler (14) has at least one first and one second flow path that are connected thermally but not in a fluid-conducting manner. A coolant can flow through the first flow path and the second flow path is connected in a fluid-conducting manner with a coffee outlet (5) of the brewing unit (4). The device also has a fresh-water supply (2) and a fresh-water cooler (13) formed as an additional heat exchanger.
    Type: Application
    Filed: July 15, 2010
    Publication date: January 20, 2011
    Applicant: NIRO-PLAN AG
    Inventors: Stefan Stahl, Mariano Turi, Heinz Vetterli
  • Publication number: 20100237517
    Abstract: A device for foaming liquid foods in a container, particularly milk, is provided having a vapor generator for generating vapors, particularly steam, and a vapor lance to be at least partially inserted into the container, with the vapor lance being connected to the vapor generator in a fluid-guiding fashion and including at least one vapor outlet opening such that steam can be discharged from the vapor generator via the vapor lance out of the vapor outlet opening. The device further includes at least one motion element which is connected to the vapor lance and/or a holder for the container such that the vapor lance and the container are movable relative to each other via the motion element.
    Type: Application
    Filed: March 17, 2010
    Publication date: September 23, 2010
    Applicant: NIRO-PLAN AG
    Inventors: Stefan Stahl, Corinne Keiser, Jochen Ganz, Adrian Burri
  • Publication number: 20100048868
    Abstract: A polypeptide is provided, which has a binding affinity for HER2 and which is related to a domain of staphylococcal protein A (SPA) in that the sequence of the polypeptide corresponds to the sequence of the SPA domain having from 1 to about 20 substitution mutations. Nucleic acid encoding the polypeptide, as well as expression vector and host cell for expressing the nucleic acid, are also provided. Also provided is the use of such a polypeptide as a medicament, and as a targeting agent for directing substances conjugated thereto to cells overexpressing HER2. Methods, and kits for performing the methods, are also provided, which methods and kits rely on the binding of the polypeptide to HER2.
    Type: Application
    Filed: June 30, 2004
    Publication date: February 25, 2010
    Applicant: AFFIBODY AB
    Inventors: Jorgen Carlsson, Stefan Stahl, Tove Eriksson, Elin Gunneriusson, Fredrik Nilsson
  • Publication number: 20090016957
    Abstract: This invention relates to polypeptides which bind to EGFR family receptors and to applications of those polypeptides in medicine, veterinary medicine, diagnosis diagnostics and imaging.
    Type: Application
    Filed: December 5, 2006
    Publication date: January 15, 2009
    Inventors: Fredrik Nilsson, Tove Eriksson, Andreas Jonsson, Stefan Stahl, Mikaela Friedman
  • Publication number: 20040005669
    Abstract: The present invention provides a method of producing an insulin C-peptide, which comprises expressing in a host cell a multimeric polypeptide comprising multiple copies of a said insulin C-peptide, and cleaving said expressed polypeptide to release single copies of the insulin C-peptide.
    Type: Application
    Filed: May 6, 2003
    Publication date: January 8, 2004
    Inventors: Stefan Stahl, Mathias Uhlen, Per-Ake Nygren, Per Jonasson
  • Patent number: 6574640
    Abstract: The present invention relates to flexible facilities for supplying documents where the index to the documents is stored in a central archive but the documents themselves are stored in an external archiving system. The solution according to the invention is based on management of the addresses in the external archiving systems which is undertaken at the central archive. The approach adopted supports the specifying of any desired number of backup servers and, by allowing the configurable supply either of the address relation itself and/or of server address information attached to the list of search results, it provides a facility which supports the full range of document supply capabilities available when a central archive system is being used.
    Type: Grant
    Filed: August 15, 2000
    Date of Patent: June 3, 2003
    Assignee: International Business Machines Corporation
    Inventor: Stefan Stahl
  • Patent number: 6558924
    Abstract: The present invention provides a method of producing an insulin C-peptide, which comprises expressing in a host cell a multimeric polypeptide comprising multiple copies of the insulin C-peptide, and cleaving the expressed polypeptide to release single copies of the insulin C-peptide. Also provided are nucleic acid molecules, expression vectors and host cells, for use in such a method and the multimeric insulin C-peptide polypeptide expressed and cleaved in such a method.
    Type: Grant
    Filed: February 7, 2000
    Date of Patent: May 6, 2003
    Assignee: Creative Peptides Sweden AB
    Inventors: Stefan Stahl, Mathias Uhlen, Per-Ake Nygren, Per Jonasson
  • Patent number: 6558673
    Abstract: A complex of an immunogen and a support molecule, characterized in that the immunogen is coupled covalently to a support molecule, wherein the support molecule is a polypeptide fragment which is able to bind specifically to mammalian serum albumin is disclosed. The invention also relates to the use of such complexes to treat RSV infection, as well as vaccines derived from such complexes.
    Type: Grant
    Filed: July 27, 2000
    Date of Patent: May 6, 2003
    Assignee: Pierre Fabre Medicament
    Inventors: Hans Binz, Thien Ngoc Nguyen, Christine Andreoni, Ake Per Nygren, Stefan Stahl, Mathias Uhlen
  • Patent number: 6149911
    Abstract: The present invention relates to a process for improving the immunogenicity of an immunogen, an antigen or a hapten, when it is administered to a host, independently of the mode of administration, characterized in that the said antigen or hapten is coupled covalently to a support molecule in order to form a complex, and in that this support molecule is a polypeptide fragment which is able to bind specifically to mammalian serum albumin. The invention also relates to the use, as a medicament, of the product which can be obtained in this way.
    Type: Grant
    Filed: July 1, 1997
    Date of Patent: November 21, 2000
    Assignee: Pierre Fabre Medicament
    Inventors: Hans Binz, Thien Nguyen Ngoc, Christine Andreoni, Per Ake Nygren, Stefan Stahl, Mathias Uhlen
  • Patent number: 6130091
    Abstract: A method for obtaining a Staphylococcus carnosus bacterium expressing at its membrane surface a recombinant polypeptide derived from RSV protein G, said polypeptide having a sequence which is a modification of SEQ ID No. 1 and SEQ ID No. 2 (sequence encompassed between residues 130 and 230 of RSV A and RSV B protein G respectively) wherein at least one of position 44 and 57 is serine is disclosed.
    Type: Grant
    Filed: July 1, 1997
    Date of Patent: October 10, 2000
    Inventors: Hans Binz, Thien Nguyen Ngoc, Stefan Stahl, Mathias Uhlen, Per Ake Nygren
  • Patent number: 5616773
    Abstract: Preparation of 5-cyanovalerates (I) by the carbonylation of a 1-cyanobutene with carbon monoxide and an alkanol (II) corresponding to the ester radical at an elevated temperature and under superatmospheric pressure in the presence of a cobalt catalyst as well as in the presence of an activating solvent, in which the activating solvent used is an effective amount of a urea of the formula IIIcR.sub.2 N--CO--NR.sub.2 (IIIc)where R is, C.sub.1 -C.sub.6 -alkyl, C.sub.5 -C.sub.7 -cycloalkyl or where 2R groups together form 5-membered to 7-membered rings. The end products I serve as intermediates, chiefly for the preparation of .epsilon.-caprolactam.
    Type: Grant
    Filed: April 10, 1995
    Date of Patent: April 1, 1997
    Assignee: BASF Aktiengesellschaft
    Inventors: Stefan Stahl, Wolfgang Harder, Arthur Hoehn
  • Patent number: 5434290
    Abstract: Preparation of 5-cyanovalerates (I) by the carbonylation of a 1-cyanobutene with carbon monoxide and an alkanol (II) corresponding to the ester radical at an elevated temperature and under superatmospheric pressure in the presence of a cobalt catalyst as well as in the presence of an activating solvent, in which the activating solvent used is an effective amount of a carbonic diester, a carbamate, or a urea of the general formula IIIa, IIIb, or IIIcR--O--CO--O--R (IIIa)R.sub.2 N--CO--O--R (IIIb)R.sub.2 N--CO--NR.sub.2 (IIIc)or a mixture of these compounds (R's same or different, C.sub.1 -C.sub.6 alkyl, C.sub.5 -C.sub.7 cycloalkyl groups or together form 5-membered to 7-membered rings).The end products I serve as intermediates, chiefly for the preparation of .epsilon.-caprolactam.
    Type: Grant
    Filed: February 28, 1994
    Date of Patent: July 18, 1995
    Assignee: BASF Aktiengesellschaft
    Inventors: Stefan Stahl, Wolfgang Harder, Arthur Hoehn
  • Patent number: 5264580
    Abstract: A process for preparing isoxazole-3,4-dicarboxylic acid derivatives of the formula I ##STR1## where R.sup.1 is hydrogen, alkyl, cycloalkyl or phenyl, or a 5- to 6-membered heterocyclic radical, and the organic radicals can have substituents which are inert under the reaction conditions;R.sup.2 is hydrogen, alkyl, cycloalkyl, benzyl or C.sub.3 -C.sub.6 -alkenyl;A is NR.sup.3 R.sup.4 where R.sup.3 is hydrogen or an aliphatic or cycloaliphatic radical and R.sup.4 is an aliphatic or cycloaliphatic radical or unsubstituted or substituted phenyl, or R.sup.3 forms together with R.sup.4 a 4- to 7-membered alkylene chain which can be interrupted by oxygen, sulfur or N-methyl, or is OR.sup.5 where R.sup.5 is alkyl, cycloalkyl, benzyl or alkenyl;by deprotonation of a CH-acid compound of the formula II ##STR2## using a base and reacting with hydroximyl chlorides of the formula III ##STR3## wherein a magnesium alcoholate of the formula IVMg(OR.sup.6 ).sub.2 IVwhere R.sup.
    Type: Grant
    Filed: March 23, 1993
    Date of Patent: November 23, 1993
    Assignee: BASF Aktiengesellschaft
    Inventors: Volker Maywald, Thomas Kuekenhoehner, Peter Muenster, Stefan Stahl